21 CFR · Food and Drugs
§ 520.136 — Atinvicitinib tablets.
eCFR · current through Jul 29, 2026
§ 520.136 Atinvicitinib tablets.
(a)Specifications. Each tablet contains 4.8, 7.2, 21.6, or 31.6 milligrams (mg) of atinvicitinib.
(b)Sponsor. See No. 000061 in § 510.600(c) of this chapter.
(c)Conditions of use—
(1)Amount. Administer 0.36 to 0.54 mg atinvicitinib per pound (0.8 to 1.2 mg atinvicitinib per kilogram) of body weight, once daily, with food.
(2)Indications for use. For the control of pruritus associated with allergic dermatitis in dogs 6 months of age and older.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[91 FR 41559, July 7, 2026]
Free access — add to your briefcase to read the full text and ask questions with AI
21 C.F.R. § 520.136 (Atinvicitinib tablets.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
§ 510.600
21 C.F.R. § 510.600
Nearby Sections
11
§ 520.90a
Ampicillin tablets.§ 520.90b
Ampicillin capsules.§ 520.90c
Ampicillin boluses.§ 520.100
Amprolium.§ 520.110
Apramycin sulfate soluble powder.§ 520.136
Atinvicitinib tablets.§ 520.154
Bacitracin oral dosage forms.§ 520.154a
Bacitracin methylenedisalicylate.§ 520.154c
Bacitracin zinc soluble powder.§ 520.170
Bexagliflozin.